deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT00193635

Pilot Study of Mycophenolate Mofetil in Congenital Uropathies

Sponsor: Hoffmann-La Roche

Conditions Congenital Urological Abnormalities
Interventions mycophenolate mofetil
Updated 6 times since 2017 Last updated: Oct 17, 2007 Started: Mar 31, 2002 Completion: Aug 31, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Congenital Urological Abnormalities and is currently completed. Hoffmann-La Roche leads this study, which shows 6 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted~Jan 2026 – present · 3 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Jan 2026 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Present [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Mar 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hoffmann-La Roche
  • New York Presbyterian Hospital
  • Northwell Health
  • University of Medicine and Dentistry of New Jersey
Data source: Northwell Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations